Search results for "Hydrazide"

showing 10 items of 87 documents

Preparation and molecular structures of N′-(2-heteroarylmethylidene)-3-(3-pyridyl)acrylohydrazides

2018

Abstract The crystal and molecular structures of N′-(2-furylmethylidene)-3-(3-pyridyl)acrylohydrazide and N′-(2-thienylmethylidene)-3-(3-pyridyl)acrylohydrazide are reported, and the influence of the type of the heteroatom on the aromaticity of the aromatic rings is discussed. Both molecules are nearly planar. The geometry of the acrylohydrazide arrangement is comparable to that of homologous compounds. Density functional theory (DFT) calculations were performed in order to analyze the changes in the geometry of the studied compounds in the crystalline state and for the isolated molecule. The most significant changes were observed in the values of the N–N and C–N bond lengths. The harmonic …

0301 basic medicinecrystal structure010405 organic chemistryChemistryacroylhydrazidesaromaticityGeneral ChemistryX-ray structure determination01 natural sciences0104 chemical sciences03 medical and health sciences030104 developmental biologyPolymer chemistryquantum chemical calculationsdensity functional theoryheteroaryl substituentsZeitschrift für Naturforschung B
researchProduct

CCDC 956724: Experimental Crystal Structure Determination

2013

Related Article: M. O. Plutenko, R. D. Lampeka, M. Haukka and E. Nordlander|2013|Acta Crystallogr.,Sect.E:Struct.Rep.Online|69|o765|doi:10.1107/S1600536813009628

2-(35-Dimethyl-1H-pyrazol-1-yl)-2-(hydroxyimino)-N'-(1-(pyridin-2-yl)ethylidene)acetohydrazideSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 914350: Experimental Crystal Structure Determination

2013

Related Article: M.O.Plutenko, R.D.Lampeka, M.Haukka, E.Nordlander|2012|Acta Crystallogr.,Sect.E:Struct.Rep.Online|68|o3381|doi:10.1107/S1600536812045412

2-(35-Dimethyl-1H-pyrazol-1-yl)-2-(hydroxyimino)-N'-(1-(pyridin-2-yl)ethylidene)acetohydrazideSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

A second monoclinic polymorph of 2-(3,5-dimethyl-1H-pyrazol-1-yl)-2-hydroxyimino-N'-[1-(pyridin-2-yl)ethylidene]acetohydrazide

2013

[Introduction] The title compound, C 14 H 16 N 6 O 2 , is a second monoclinic polymorph of 2-[1-(3,5-dimethyl)pyrazolyl]-2-hydroxyimino- N 0 -[1-(2-pyridyl)ethylidene] acetohydrazide, with two crystal- lographically independent molecules per asymmetric unit. The non-planar molecules are chemically equal having similar geometric parameters. The previously reported polymorph [Plutenko et al. (2012). Acta Cryst. E 68 , o3281] was described in space group Cc ( Z = 4). The oxime group and the O atom of the amide group are anti with respect to the C—C bond. In the crystal, molecules are connected by N—H N hydrogen bonds into zigzag chains extending along the b axis. peerReviewed

2-[1-(35-dimethyl)pyrazolyl]-2-hydroxyimino-N'-[1-(2-pyridyl)ethylidene] acetohydrazide
researchProduct

Polyaspartylhydrazide Copolymer-Based Supramolecular Vesicular Aggregates as Delivery Devices for Anticancer Drugs

2008

In this paper we report on three different hydrophilic copolymers based on alpha,beta-polyaspartylhydrazide (PAHy) bearing butyric groups in the side chain (C 4) (PAHy-C 4) or a combination of butyric groups and positive charged residues ((carboxypropyl)trimethylammonium chloride, CPTACl) (PAHy-C 4-CPTA) that were synthesized and used for the preparation of new supramolecular vesicular aggregates (SVAs) containing gemcitabine as an antitumor drug. Gemcitabine-loaded SVAs containing synthesized PAHy derivatives were characterized from the physicochemical and technological point of view and the in vitro toxicity and anticancer activity on two different human cancer cell lines, i.e., CaCo-2 (h…

Antimetabolites AntineoplasticMagnetic Resonance SpectroscopyPolymers and PlasticsPolymerssupramolecular aggregates polyaspartylhydrazide copolymersSupramolecular chemistryApoptosisBioengineeringDeoxycytidineBiomaterialsButyric acidchemistry.chemical_compoundDrug Delivery SystemsTumor Cells CulturedMaterials ChemistrySide chainCopolymerHumansThyroid NeoplasmsCytotoxicityCells CulturedChromatography High Pressure LiquidDrug CarriersMolecular StructureChemistryVesicleFlow CytometryGemcitabineIn vitroBiochemistryColonic NeoplasmsChromatography GelPeptidesDrug carrierBiomacromolecules
researchProduct

Dielectric Behavior of Aqueous Solutions of α,β-Poly(aspartyl hydrazide) and α,β-Poly(N-hydroxyethyl aspartamide): An Investigation of the Structural…

1994

The dielectric properties of aqueous solutions of α,β-poly(aspartyl hydrazide) (PAHy) and of α,β-poly( N-hydroxyethyl aspartamide) (PHEA) were measured at 25 ° C in the frequency range of 100 MHz to 15 GHz using a time domain reflection method (TDR). Single time relaxation processes were found at 2 GHz and 15 GHz, respectively. The low frequency dispersion was inter preted in terms of the dynamics of polymeric segments based on the dielectric relaxation strength and the relaxation time. The high frequency process which is attributed to the rotational relaxation of water, indicated that water mole cules surrounding the polymeric backbone and in the pure state have a similar rotational behav…

Aqueous solutionPolymers and PlasticsRelaxation strength0206 medical engineeringRelaxation (NMR)Analytical chemistryBioengineering02 engineering and technologyDielectricLow frequency021001 nanoscience & nanotechnologyHydrazide020601 biomedical engineeringBiomaterialschemistry.chemical_compoundCrystallographyReflection (mathematics)chemistryMaterials Chemistry0210 nano-technologyDispersion (chemistry)Journal of Bioactive and Compatible Polymers
researchProduct

Folate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugs.

2010

Supramolecular vesicular aggregates (SVAs) have the advantage of combining the safe and biocompatible properties of colloidal vesicular carriers based on phospholipids with those of polymeric materials, i.e. polyaspartyl-hydrazide (PAHy) copolymers. To provide SVAs with a certain tumour selectivity, folate moieties were chemically conjugated to PAHy copolymers. Physicochemical properties (mean sizes, polydispersity index and zeta potential) of folate-targeted SVAs (FT-SVAs) loaded with gemcitabine were evaluated. The antiproliferative and anticancer activity of gemcitabine-loaded FT-SVAs was evaluated against two cancer cell lines, i.e. MCF-7 cells which over-express the folate receptor and…

AzidesMaterials sciencePolymersBiophysicsBioengineeringAntineoplastic AgentsBiocompatible MaterialsPharmacologyDeoxycytidineFlow cytometryBiomaterialsDrug Delivery SystemsFolic AcidIn vivoCell Line TumorMaterials TestingmedicineHumansTissue DistributionCytotoxicityLiposomeDrug CarriersMicroscopy Confocalmedicine.diagnostic_testMolecular StructureGemcitabineIn vitroDRUG DELIVERY POLYASPARTYLHYDRAZIDE FOLATESettore CHIM/09 - Farmaceutico Tecnologico ApplicativoMechanics of MaterialsCell cultureFolate receptorDrug deliveryCeramics and CompositesBiophysicsPeptidesBiomaterials
researchProduct

Cationic Supramolecular Vesicular Aggregates for Pulmonary Tissue Selective Delivery in Anticancer Therapy

2016

The biopharmaceutical properties of supramolecular vesicular aggregates (SVAs) were characterized with regard to their physicochemical features and compared with cationic liposomes (CLs). Neutral and cationic SVAs were synthesized using two different copolymers of poly(aspartyl hydrazide) by thin-layer evaporation and extrusion techniques. Both copolymers were self-assembled in pre-formulated liposomes and formed neutral and cationic SVAs. Gemcitabine hydrochloride (GEM) was used as an anticancer drug and loaded by a pH gradient remote loading procedure, which significantly increased drug loading inside the SVAs. The resulting average size of the SVAs was 100 nm. The anticancer activity of …

DrugBiodistributionMacromolecular Substancesmedia_common.quotation_subjectSupramolecular chemistryAntineoplastic Agents02 engineering and technology010402 general chemistryHydrazideDeoxycytidine01 natural sciencesBiochemistryGemcitabine Hydrochloridesupramolecular chemistryStructure-Activity Relationshipchemistry.chemical_compoundDrug Delivery SystemsCationsDrug DiscoveryTumor Cells CulturedAnimalsHumansTissue DistributionCationic liposomeRats WistarGeneral Pharmacology Toxicology and Pharmaceuticsvesicular aggregatesCell Proliferationmedia_commonPharmacologyLiposomeDose-Response Relationship DrugMolecular StructurenanoparticleOrganic ChemistryCationic polymerization021001 nanoscience & nanotechnologyGemcitabineRats0104 chemical scienceschemistryBiochemistryantitumor agentliposomeMolecular MedicineDrug Screening Assays Antitumor0210 nano-technologyChemMedChem
researchProduct

Novel cationic polyaspartamide with covalently linked carboxypropyl-trimethyl ammonium chloride as a candidate vector for gene delivery

2006

Abstract The non-viral gene vector properties of a protein-like polymer, the α,β-poly(N-2-hydroxyethyl)- d , l -aspartamide (PHEA) were investigated after its derivatization with 3-(carboxypropyl)trimethyl-ammonium chloride (CPTA) as molecule bearing cationic groups, in order to obtain stable polycations able to condense DNA. PHEA was firstly functionalized with hydrazide pendant groups by reaction with hydrazine monohydrate (HYD), obtaining the polyhydrazide α,β-poly(N-2-hydroxyethyl/carbazate)- d , l -aspartamide (PHEA–HYD). In this paper we reported that polymer functionalization degree can be easily modulated by varying reaction conditions, so allowing us to produce two PHEA derivatives…

Hydrodynamic radiusPolymers and PlasticsStereochemistryOrganic ChemistryCationic polymerizationGeneral Physics and AstronomyChemical modification3-(carboxypropyl) trimethyl ammonium chlorideCondensation reactionHydrazideChloridePolyelectrolytesynthetic gene vectorpolycationalphabeta-poly(N-2-hydroxyethyl)-DL-aspartamide (PHEA)chemistry.chemical_compoundchemistryPolymer chemistryMaterials ChemistrymedicineAmmonium chloridepolyplexemedicine.drugEuropean Polymer Journal
researchProduct

HYDROGELS OF HYALURONIC ACID AND alpha, beta-POLYASPARTYLHYDRAZIDE AND THEIR BIOMEDICAL AND PHARMACEUTICAL USES

2005

Compositions and products based on the chemical crosslinking of hyaluronic acid with a polyfunctional polymer having a protein-like structure, bearing hydrazido pendent groups along the polymeric chain. The polymer is preferably, alpha-beta-polyaspartylhydrazide, a biocompatible macromolecule. The materials obtained after crosslinking, specifically hydrogels, undergo a reduced chemical and enzymatic degradation, unlike the starting hyaluronic acid, and they can be used to prepare systems for applications in the biomedical and pharmaceutical field.

Hydrogels hyaluronic acid alpha beta-polyaspartylhydrazide
researchProduct